Maria Dimopoulou | Agricultural and Biological Sciences | Research Excellence Award

Published on by Global Scholar Awards

Dr. Maria Dimopoulou | Agricultural and Biological Sciences | Research Excellence Award

University of Thessaly | Greece

Dr. Maria Dimopoulou is an emerging academic researcher at the University of Thessaly, Volos, Greece, with scholarly expertise in nutritional science, public health, and culinary medicine, particularly in the management of chronic metabolic disorders such as Type II Diabetes Mellitus. She has authored 10 peer-reviewed publications, accumulating 187 citations and an h-index of 5, reflecting growing academic visibility and research relevance. Her work emphasizes evidence-based dietary interventions, nutritional profiling of meals, and lifestyle-oriented clinical strategies, as demonstrated by her open-access review on culinary medicine and diabetes care. Dr. Dimopoulou actively collaborates with multidisciplinary research teams, contributing to clinical nutrition, preventive healthcare, and patient-centered dietary planning. The societal impact of her research lies in promoting sustainable, practical, and culturally adaptable nutritional approaches that support chronic disease management and improve quality of life. Through continued research dissemination and collaboration, she contributes meaningfully to global efforts in nutrition-driven healthcare innovation.

Citation Metrics (Scopus)

187
150
100
50
0

Citations

187

Documents

10

h-index

5

Citations

Documents

h-index

View Scopus Profile
 View ORCID Profile

Featured Publications

Hywel Williams | Genomic Medicine | Best Researcher Award

Published on by Global Scholar Awards

Dr. Hywel Williams | Genomic Medicine | Best Researcher Award

Senior Lecturer | Cardiff University | United Kingdom

Dr. Hywel J. Williams is a distinguished academic and researcher currently serving as a Senior Lecturer in Bioinformatics: Genetic and Genomic Medicine in the Division of Cancer and Genetics, School of Medicine, Cardiff University, since 2019. He holds a Ph.D. in Genetics from Cardiff University (2001–2005), where his research focused on identifying schizophrenia susceptibility genes on chromosome 22 under the supervision of Prof. Sir Michael J. Owen. His earlier academic qualifications include a B.Sc. (Hons) in Genetics from Cardiff University (1994–1996) and an HND in Applied Biology from the University of Wales Institute Cardiff (1992–1994). Dr. Williams also earned recognition as an Associate Fellow of the Higher Education Academy in 2018. With over two decades of research experience, his career spans roles such as Senior Research Associate at UCL’s Great Ormond Street Institute of Child Health (2013–2018), and various research positions at Cardiff University from 1997 to 2012. His work integrates bioinformatics, genomics, and molecular genetics, with a primary focus on rare diseases, psychiatric genetics, and genomic medicine. His key contributions include joint first authorship of the landmark study “The 100,000 Genomes Pilot on Rare Disease Diagnosis in Healthcare” published in the New England Journal of Medicine (2021), and senior authorship in studies enhancing rapid pediatric sequencing and understanding of genetic disorders. Dr. Williams possesses advanced research skills in genomic data analysis, variant interpretation, computational biology, and multi-omic integration, contributing to the clinical translation of genome sequencing technologies. With an outstanding academic record—over 19,000 citations, an h-index of 56, and an i10-index of 101—he is recognized for his influential work in genomic research and data-driven healthcare. His career reflects a commitment to improving diagnostic accuracy and patient care through innovative bioinformatics approaches, making him a key contributor to the global advancement of precision and personalized medicine.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Purcell, S. M., Wray, N. R., Stone, J. L., Visscher, P. M., O’Donovan, M. C., Sullivan, P. F., Williams, H. J., et al. (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460(7256), 748–752. https://doi.org/10.1038/nature08185 Cited by: 5,521

  2. Schizophrenia Working Group of the Psychiatric Genomics Consortium. (2011). Genome-wide association study identifies five new schizophrenia loci. Nature Genetics, 43(10), 969–976. https://doi.org/10.1038/ng.940 Cited by: 2,110

  3. Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., et al. (2014). De novo mutations in schizophrenia implicate synaptic networks. Nature, 506(7487), 179–184. https://doi.org/10.1038/nature12929 Cited by: 1,920

  4. O’Donovan, M. C., Craddock, N., Norton, N., Williams, H., Peirce, T., Moskvina, V., et al. (2008). Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nature Genetics, 40(9), 1053–1055. https://doi.org/10.1038/ng.201 Cited by: 1,327

  5. 100,000 Genomes Project Pilot Investigators (including Williams, H. J.). (2021). 100,000 genomes pilot on rare-disease diagnosis in health care—preliminary report. New England Journal of Medicine, 385(20), 1868–1880. https://doi.org/10.1056/NEJMoa2035790 Cited by: 657

Letícia Estevinho | Biotecnology | Best Researcher Award

Published on by Global Scholar Awards

Prof. Letícia Estevinho | Biotecnology | Best Researcher Award

head teacher at Escola Superior Agrária -IPB, Portugal

Prof. Dr. Leticia M. Estevinho is a distinguished researcher with over 35 years of academic and scientific experience at the Polytechnic Institute of Bragança, Portugal. She holds a PhD in Science and has completed the highest academic qualification in Portugal, the Agregação. Her prolific research career includes over 200 published articles in indexed journals, 325+ scientific communications, five book chapters, and four patents. As principal investigator of more than 30 fully funded research projects, she has demonstrated exceptional leadership. She has supervised 23 PhD students and 10 postdoctoral researchers and has served as Head of the Microbiology Laboratory since 1986. Additionally, she has contributed significantly to the scientific community through her roles as editor-in-chief of three journals, editorial board member of 50 international journals, and reviewer of over 500 manuscripts. Her consistent academic excellence, mentorship, and research productivity make her a highly suitable candidate for the Best Researcher Award.

Professional Profile

Education🎓

Prof. Dr. Leticia M. Estevinho has a strong and distinguished academic background in the fields of science and biotechnology. She earned her degree in Zootechnical Engineering in 1985 with the highest honors (summa cum laude), reflecting her early academic excellence. She went on to complete a Master of Science degree in Biotechnology in 1989, also with merit, further strengthening her expertise in applied biological sciences. In 1995, she obtained her PhD in Science from the University of Minho in Braga, Portugal, marking a significant milestone in her research career. In 2009, she successfully completed the Agregação, the most advanced academic qualification in the Portuguese academic system, which is a testament to her scholarly depth and leadership in research. This solid educational foundation has supported her long-standing career in academia, research, and mentoring, enabling her to contribute extensively to scientific knowledge and innovation in microbiology and biotechnology.

Professional Experience📝

Prof. Dr. Leticia M. Estevinho has amassed over 35 years of professional experience in academia and scientific research, primarily at the Agricultural College of Bragança, Polytechnic Institute of Bragança, Portugal. Since 1986, she has served as a faculty member, progressing to the role of Full Professor. She is the Head of the Microbiology Laboratory, a position she has held since the beginning of her career, where she has led extensive research and academic initiatives. Prof. Estevinho has supervised 23 PhD students and 10 postdoctoral researchers, reflecting her strong commitment to mentorship and academic development. She has also been the principal investigator of over 30 fully funded research projects, showcasing her leadership and project management capabilities. Her editorial contributions are extensive, having served as editor-in-chief for three journals and on the editorial boards of 50 others. Her experience spans teaching, research, administration, and international collaboration, making her a respected leader in her field.

Research Interest🔎

Prof. Dr. Leticia M. Estevinho’s research interests lie primarily in microbiology, biotechnology, and their applications in agriculture, food science, and environmental sustainability. Her work focuses on the antimicrobial properties of natural products, particularly honey and propolis, and their potential use in food preservation and health. She is also deeply engaged in studying microbial behavior, resistance mechanisms, and the development of innovative biotechnological solutions to improve food safety and quality. Her research extends to applied microbiology in agricultural systems, exploring ways to enhance productivity while maintaining ecological balance. Prof. Estevinho is known for integrating fundamental science with practical applications, often contributing to the development of new products and patents. Her interdisciplinary approach combines biology, chemistry, and environmental sciences, enabling her to address complex challenges in both academic and industrial settings. Her work not only advances scientific knowledge but also supports sustainable practices and public health improvement through biotechnology.

Award and Honor🏆

Prof. Dr. Leticia M. Estevinho has earned widespread recognition throughout her distinguished career for her exceptional contributions to science, research, and education. While specific awards and honors are not detailed in the provided biography, her academic distinctions, such as graduating summa cum laude in Zootechnical Engineering and completing her M.S. and PhD with merit, reflect consistent excellence from the outset of her academic journey. Her successful completion of the prestigious Agregação qualification in 2009 further highlights her scholarly achievement and academic leadership. Prof. Estevinho’s international standing is evidenced by her role as editor-in-chief of three scientific journals and editorial board membership in 50 respected international journals—positions typically reserved for highly accomplished and respected researchers. Additionally, her role as a peer reviewer for over 500 scientific articles demonstrates the trust the academic community places in her expertise. These roles serve as implicit honors that affirm her influence and stature in the scientific world.

Research Skill🔬

Prof. Dr. Leticia M. Estevinho possesses a comprehensive and advanced set of research skills that reflect her extensive experience in microbiology, biotechnology, and related fields. She demonstrates strong expertise in experimental design, microbial analysis, natural product testing, and data interpretation. Her ability to lead and manage large-scale scientific projects is evident from her role as principal investigator in over 30 fully funded research initiatives. She is skilled in laboratory management, having led the Microbiology Laboratory at the Polytechnic Institute of Bragança since 1986. Her proficiency in scientific writing is highlighted by the publication of more than 200 indexed journal articles, multiple book chapters, and patents. Additionally, her experience in mentoring PhD and postdoctoral researchers showcases her capacity to guide complex research processes. Her editorial work and extensive peer-review contributions further demonstrate her critical analysis, scientific rigor, and strong understanding of current trends and standards in scientific research and publication.

Conclusion💡

Prof. Dr. Leticia M. Estevinho is highly suitable for the Best Researcher Award. Her career reflects a deep commitment to research excellence, mentorship, and scientific leadership. The volume and consistency of her contributions, especially her mentorship and editorial responsibilities, are outstanding.

While a bit more emphasis on global impact metrics and innovation frontiers would enhance the application, her existing achievements clearly place her among top-tier researchers deserving of recognition.

Publications Top Noted✍

  • Title: Biological activities of endophytic fungi isolated from Annona muricata Linnaeus: a systematic review
    Authors: I. M. M. Silva, R. M. Silva, V. B. Paula, L. M. Estevinho
    Year: 2024
    Citation: Silva, I. M. M., Silva, R. M., Paula, V. B., & Estevinho, L. M. (2024). Biological activities of endophytic fungi isolated from Annona muricata Linnaeus: a systematic review. Brazilian Journal of Biology. https://doi.org/10.1590/1519-6984.259525

  • Title: Volatile characterization of honey with dominance of Bupleurum spinosum pollen
    Authors: Youssef Elamine, Alexandra M. Machado, Letícia M. Estevinho, Badiâa Lyoussi, Ana Cristina Figueiredo, Maria Graça Miguel
    Year: 2024 (Published online: 2023-10-19)
    Citation: Elamine, Y., Machado, A. M., Estevinho, L. M., Lyoussi, B., Figueiredo, A. C., & Miguel, M. G. (2024). Volatile characterization of honey with dominance of Bupleurum spinosum pollen. Journal of Apicultural Research. https://doi.org/10.1080/00218839.2023.2232124

  • Title: Antibacterial and Healing Effect of Chicha Gum Hydrogel (Sterculia striata) with Nerolidol
    Authors: Idglan Sá de Lima, Maria Onaira Gonçalves Ferreira, Esmeralda Maria Lustosa Barros, Marcia dos Santos Rizzo, Jailson de Araújo Santos, Alessandra Braga Ribeiro, Josy Anteveli Osajima Furtini, Edson C. Silva-Filho, Leticia M. Estevinho
    Year: 2023
    Citation: Lima, I. S. de, Ferreira, M. O. G., Barros, E. M. L., Rizzo, M. S., Santos, J. A., Ribeiro, A. B., Furtini, J. A. O., Silva-Filho, E. C., & Estevinho, L. M. (2023). Antibacterial and Healing Effect of Chicha Gum Hydrogel (Sterculia striata) with Nerolidol.

  • Title: Antimicrobial Activity of Propolis from the Brazilian Stingless Bees Melipona quadrifasciata anthidioides and Scaptotrigona depilis (Hymenoptera, Apidae, Meliponini)
    Authors: Jaqueline Ferreira Campos, Thaliny Bonamigo, Paola dos Santos da Rocha, Vanessa Marina Branco Paula, Uilson Pereira dos Santos, José Benedito Perrella Balestieri, Denise Brentan Silva, Leticia M. Estevinho, et al.
    Year: 2023
    Citation: Campos, J. F., Bonamigo, T., Rocha, P. S. da, Paula, V. M. B., Santos, U. P. dos, Balestieri, J. B. P., Silva, D. B., Estevinho, L. M., et al. (2023). Antimicrobial activity of propolis from Brazilian stingless bees.

  • Title: Botanical origin, physicochemical characterization, and antioxidant activity of bee pollen samples from the northeast of Portugal
    Authors: Ananias Pascoal, Émerson Dechechi Chambó, Leticia M. Estevinho
    Year: 2023
    Citation: Pascoal, A., Chambó, É. D., & Estevinho, L. M. (2023). Botanical origin, physicochemical characterization, and antioxidant activity of bee pollen samples from the northeast of Portugal.

  • Title: Chemotherapeutic properties and side-effects associated with the clinical practice of terpene alkaloids: paclitaxel, docetaxel, and cabazitaxel
    Authors: Mário Sousa-Pimenta, Letícia M. Estevinho, Agnieszka Szopa, Mahnoor Basit, Muhammad Armaghan, Manshuk Ibrayeva, Eda Sönmez Gürer, et al.
    Year: 2023
    Citation: Sousa-Pimenta, M., Estevinho, L. M., Szopa, A., Basit, M., Armaghan, M., Ibrayeva, M., Gürer, E. S., et al. (2023). Chemotherapeutic properties and side-effects of terpene alkaloids: paclitaxel, docetaxel, and cabazitaxel.

  • Title: Comparative Methods to Evaluate the Antioxidant Capacity of Propolis: An Attempt to Explain the Differences
    Authors: Vanessa B. Paula, Leticia M. Estevinho, Susana M. Cardoso, Luís G. Dias
    Year: 2023
    Citation: Paula, V. B., Estevinho, L. M., Cardoso, S. M., & Dias, L. G. (2023). Comparative methods to evaluate the antioxidant capacity of propolis: An attempt to explain the differences.

  • Title: High Hydrostatic Pressure in the Modulation of Enzymatic and Organocatalysis and Life under Pressure: A Review
    Authors: Hana Scepankova, Diogo Galante, Edelman Espinoza-Suaréz, Carlos A. Pinto, Leticia M. Estevinho, Jorge Saraiva
    Year: 2023
    Citation: Scepankova, H., Galante, D., Espinoza-Suaréz, E., Pinto, C. A., Estevinho, L. M., & Saraiva, J. (2023). High hydrostatic pressure in the modulation of enzymatic and organocatalysis and life under pressure: A review.

Ramiro Vivanco | Biotecnología | Best Researcher Award

Published on by Global Scholar Awards

Mr. Ramiro Vivanco | Biotecnología | Best Researcher Award

Investigador at Universidad de las Fuerzas Armadas, Ecuador

Ramiro Vivanco Gonzaga is an emerging biotechnology researcher with a strong interdisciplinary background in synthetic biology, plant biology, and artificial intelligence. As the founder of AFBiolab—supported by Microsoft for Startups—he demonstrates exceptional innovation and leadership in biotechnology research and development. His academic journey includes prestigious programs from Harvard’s Aspire Institute, Johns Hopkins University, and the Icahn School of Medicine, reflecting his commitment to continuous learning and scientific excellence. Ramiro has extensive hands-on experience in molecular biology techniques, bioinformatics, and project management, with notable roles in both environmental and biomedical sectors. He has led and collaborated on projects involving CRISPR, genome analysis, and sustainable practices. While his peer-reviewed publication record is still developing, his practical contributions and startup leadership highlight significant research potential. With a growing global presence and a drive for impactful science, Ramiro is a strong candidate for recognition through the Best Researcher Award.

Professional Profile:

Education

Ramiro Vivanco Gonzaga has pursued a dynamic and interdisciplinary educational path focused on biotechnology, systems biology, and data science. He is currently enrolled in the prestigious Aspire Leaders Program at the Aspire Institute, supported by Harvard University, which cultivates leadership and innovation among emerging scientists. He earned his degree in Biotechnology Engineering from the Universidad de las Fuerzas Armadas – ESPE, where he also served as President of the Synthetic Biology Club and was awarded the Junior Researcher Award in 2024. Further expanding his expertise, Ramiro is completing specializations in Systems Biology and Biotechnology from the Icahn School of Medicine at Mount Sinai and in Bioinformatics from Johns Hopkins University, where he is developing skills in genome analysis and computational biology. Additionally, he is undergoing a Data Science Specialization from Johns Hopkins, equipping him with skills in machine learning and big data analysis. His education reflects a commitment to integrating biology, technology, and data science for innovative research.

Professional Experience

Ramiro Vivanco Gonzaga has cultivated a diverse and impactful professional background across biotechnology, bioinformatics, environmental science, and laboratory research. He is the founder of AFBiolab, a biotech startup supported by Microsoft for Startups Founders Hub, where he leads innovation in synthetic biology, artificial intelligence, and bioinformatics. Previously, he worked as a laboratory specialist at Aitia Biotech, optimizing experimental protocols and contributing to scientific advancements. As an environmental consultant for CULTEX, he conducted biodiversity assessments and promoted sustainable land practices. He also served as a coordinator for water treatment quality at UMAPAP, ensuring compliance with environmental regulations. At EMBL-EBI, he interned as a research project manager, furthering his skills in data analysis and research planning. His earlier roles include internships at IDgen and ESPE’s Tissue Culture Lab, where he gained foundational experience in molecular biology and plant biotechnology. Ramiro’s professional journey reflects a strong ability to lead, innovate, and collaborate across scientific disciplines.

Research interest

Ramiro Vivanco Gonzaga’s research interests lie at the intersection of biotechnology, synthetic biology, artificial intelligence, and environmental sustainability. He is particularly passionate about applying systems biology and bioinformatics to solve complex biological problems, including the genetic basis of diseases and the development of innovative therapeutic strategies. His work integrates molecular biology techniques such as CRISPR, genome sequencing, and cellular analysis with advanced computational tools and data science, aiming to create predictive models and smart biotechnological applications. Ramiro is also deeply interested in the role of biotechnology in promoting sustainability, especially in developing eco-friendly technologies and regenerative environmental practices. His startup, AFBiolab, reflects these ambitions by combining AI and synthetic biology for the advancement of bio-based solutions. With a strong foundation in laboratory science and a forward-thinking approach to integrating emerging technologies, Ramiro’s research is geared toward high-impact, cross-disciplinary innovations that address both human health and global ecological challenges.

Award and honor

Ramiro Vivanco Gonzaga has earned several awards and honors that reflect his dedication to scientific excellence and leadership in biotechnology. Notably, he received the Junior Researcher Award from the Universidad de las Fuerzas Armadas – ESPE in 2024, recognizing his early contributions to academic research and innovation. During his undergraduate studies, he served as President of the Synthetic Biology Club from 2021 to 2023, where he led collaborative projects and promoted student involvement in advanced biotechnological initiatives. His selection into the Aspire Leaders Program, backed by Harvard University, further highlights his potential as a future leader in science and technology. Additionally, his startup AFBiolab’s acceptance into the Microsoft for Startups Founders Hub stands as a major achievement, acknowledging his entrepreneurial spirit and groundbreaking work in integrating artificial intelligence and synthetic biology. These distinctions underscore his promise as a rising researcher committed to impactful and interdisciplinary scientific advancement.

Research skill

Ramiro Vivanco Gonzaga possesses a strong and versatile set of research skills that span molecular biology, synthetic biology, bioinformatics, and data science. He is proficient in laboratory techniques such as CRISPR, PCR/qPCR, LC-MS, genome sequencing, cell culture, and quality analysis—essential tools for modern biotechnology research. His computational expertise includes programming in Python, R, and MATLAB, along with the use of bioinformatics software for genomic analysis, data visualization, and algorithm development. Ramiro has also developed skills in machine learning and deep learning, which he integrates into biological research for predictive modeling and innovative solution development. Additionally, he is trained in experimental design, scientific writing, and project management, enabling him to lead multidisciplinary research projects effectively. His certifications in Good Manufacturing Practices (GMP), ISO standards, and project management further enhance his ability to conduct research in regulated environments. Ramiro’s blend of wet lab experience and computational proficiency positions him as a capable and innovative researcher.

Conclusion 

Ramiro Vivanco Gonzaga is a highly promising and innovative researcher who blends biotechnology and artificial intelligence with a strong orientation toward applied science and real-world impact. His leadership in startups, cross-functional lab skills, and international training reflect a research trajectory that is both ambitious and meaningful.

Publications top noted

1. Title: Consequences of Volcanic Ash on Antioxidants, Nutrient Composition, Heavy Metal Accumulation, and Secondary Metabolites in Key Crops of Cotopaxi Province, Ecuador

  • Authors: Raluca Mihai, Katherine Elizabeth Rodríguez Valencia, Nina G. Sivizaca Flores, Ramiro Fernando Vivanco Gonzaga, Nelson Santiago Cubi Insuaste, Rodica Catana

  • Year: 2025

  • Journal: Toxics

  • DOI: 10.3390/toxics13020075

  • ISSN: 2305-6304

2. Title: Impact of Babaco (Vasoncelea x pentagona (Heilborn) Mabb.) Fruit Ripening Stages on Phytochemical Composition and Biological Properties

  • Authors: Raluca Mihai, Mauricio G. Canchignia Guacollantes, Ramiro F. Vivanco Gonzaga, Nelson Santiago Cubi Insuaste, Rodica Catana

  • Year: 2024

  • Journal: Metabolites

  • DOI: 10.3390/metabo14120718

Hyun Sook Park | Medicine and Dentistry | Women Researcher Award

Published on by Global Scholar Awards

Dr. Hyun Sook Park | Medicine and Dentistry | Women Researcher Award

CEO at CEFO, South Korea

Dr. Hyun-Sook Park is an accomplished researcher and leader in the fields of stem cell science, tissue engineering, and regenerative medicine. She holds a Ph.D. in Pathology from Imperial College London, where she focused on adult stem cells in the gastrointestinal tract. As the CEO of CEFO Bio Co., Ltd, Dr. Park has spearheaded innovations in stem cell therapies and bioengineering, with significant contributions to skin regeneration and pancreatic beta-cell differentiation. Her academic career includes roles as an affiliated professor at prestigious Korean universities. Dr. Park has held key leadership positions, including serving on boards for the Korea Society of Stem Cell Research and the Korean Tissue Engineering & Regenerative Medicine. She has received numerous awards, such as the British Council Ph.D. Award and Digital Innovation Award, recognizing her groundbreaking research. Dr. Park is also actively involved in shaping national policy on biomedical sciences and advancing global research initiatives.

Professional Profile

Education

Dr. Hyun-Sook Park has a distinguished academic background, with degrees from prestigious institutions. She earned her Bachelor of Science in Biology from Korea University in Seoul (1982-1986), followed by a Master of Science in Zoology from the same university (1986-1988). Dr. Park then pursued a Ph.D. in Pathology at Imperial College London, where she focused on adult stem cells in the gastrointestinal tract and their role in cancer development and regeneration. She completed her Ph.D. under the supervision of Dr. Nicholas A. Wright in 1997, at the Imperial College School of Medicine. Her research at Imperial College, specifically on gastrointestinal epithelial stem cells, marked the beginning of her long-standing interest in stem cell science. This educational foundation laid the groundwork for her future groundbreaking contributions to stem cell research, tissue engineering, and regenerative medicine, establishing her as a leader in the biomedical field.

Professional Experience

Dr. Hyun-Sook Park has an extensive professional career in biomedical research and leadership. She is the CEO of CEFO Bio Co., Ltd, where she oversees the company’s innovative work in stem cell therapies and bioengineering. Dr. Park’s research experience spans several prestigious institutions. She served as Vice Director at BioSolution (2007-2011), focusing on human embryonic stem cells and skin regeneration. Prior to this, she was Director of the Research Institute at MizMedi Hospital Medical Research Center (2005-2007), where she studied stem cell differentiation. Dr. Park also worked as a Senior Research Scientist at the Institute of Radiological and Medical Sciences (1999-2005), specializing in tissue engineering and pancreatic beta-cell differentiation. She has held postdoctoral roles, including at the Korea Research Institute of Bioscience and Biotechnology, and was a visiting researcher at the Imperial Cancer Research Fund. Her career has also included advisory roles and leadership in scientific committees and organizations.

Research Interests

Dr. Hyun-Sook Park’s research interests are centered around stem cell science, tissue engineering, and regenerative medicine. Her early work focused on adult stem cells in the gastrointestinal tract, exploring their role in cancer development and tissue regeneration. Over the years, she expanded her research to encompass a range of biomedical applications, including human embryonic stem cell differentiation, specifically in endodermal and mesodermal lineages. Dr. Park has made significant contributions to the development of bioartificial tissues, such as skin regeneration, and the differentiation of pancreatic beta cells from stem cells for potential diabetes treatments. Her research also explores gene therapy and the use of stem cells in cancer therapies. More recently, she has been involved in advanced techniques, such as the use of ultra-sensitive nanoparticles for tracking endothelial cells. Dr. Park’s work is crucial in advancing regenerative medicine and tissue engineering, with the potential to revolutionize treatments for various diseases.

Awards and Honors

Dr. Hyun-Sook Park has received numerous prestigious awards and honors throughout her career, recognizing her exceptional contributions to scientific research and innovation. Among her accolades is the British Council Ph.D. Award (1990) for her outstanding academic achievements. She also received the Digital Innovation Award in 2014 and 2017, acknowledging her pioneering work in stem cell research and regenerative medicine. Dr. Park was awarded the Overseas Research Scholarship Award (1990-1993) and the Weston Scholarship in the Royal Postgraduate Medical School (1990-1993), which supported her studies at Imperial College London. In addition to these awards, Dr. Park’s research has been consistently recognized by the scientific community, reflected in her extensive publication record and involvement in high-impact projects. Her leadership in the field is further highlighted by her membership in influential committees and advisory roles, shaping national policies in biomedical research. These honors underscore her significant impact on science and healthcare advancements.

Conclusion

Dr. Hyun-Sook Park is an outstanding candidate for the Women Researcher Award. With her exemplary leadership in bioengineering and stem cell research, she has made tremendous contributions to the scientific community. Her innovations in regenerative medicine and cancer research, along with her leadership in key professional and governmental committees, underline her profound impact on both science and policy. While there are opportunities for her to increase her global visibility and outreach, her achievements clearly demonstrate the caliber of a distinguished researcher deserving of this prestigious award.

Publications Top Noted

  • Evaluation of Safety and Efficacy of Cell Therapy Based on Osteoblasts Derived from Umbilical Cord Mesenchymal Stem Cells for Osteonecrosis of the Femoral Head: Study Protocol for a Single-Center, Open-Label, Phase I Clinical Trial
    • Authors: Baek, S.-H., Shim, B.-J., Won, H., Park, H.S., Kim, S.-Y.
    • Year: 2024
    • Citations: 0
  • Early Osteogenic-Induced Adipose-Derived Stem Cells and Canine Bone Regeneration Potential Analyzed Using Biodegradable Scaffolds
    • Authors: Yun, H.-H., Kim, S.-G., Park, S.-I., Hong, I.-H., Jeong, K.-S.
    • Year: 2023
    • Citations: 2
  • In Vitro Tracking of Human Umbilical Vein Endothelial Cells Using Ultra-Sensitive Quantum Dot-Embedded Silica Nanoparticles
    • Authors: Kim, J., Lee, S., Lee, Y.K., Jun, B.-H., Park, H.-S.
    • Year: 2023
    • Citations: 6
  • Comparison of Temperature Equilibrium Rate and Cell Growth/Viability Under Air Circulation in Cryogenic Storage Container
    • Authors: Park, J.-Y., Lee, D.-W., Lee, S., Park, H.-S., Yoon, G.-S.
    • Year: 2022
    • Citations: 0
  • Medroxyprogesterone Reverses Tolerable Dose Metformin-Induced Inhibition of Invasion via Matrix Metallopeptidase-9 and Transforming Growth Factor-β1 in KLE Endometrial Cancer Cells
    • Authors: Suh, D.H., Lee, S., Park, H.-S., Park, N.H.
    • Year: 2020
    • Citations: 4
  • Differentiation of Equine Induced Pluripotent Stem Cells into Mesenchymal Lineage for Therapeutic Use
    • Authors: Chung, M.-J., Park, S., Son, J.-Y., Park, H.-S., Jeong, K.-S.
    • Year: 2019
    • Citations: 19
  • Establishment of Stably Expandable Induced Myogenic Stem Cells by Four Transcription Factors
    • Authors: Lee, E.-J., Kim, M., Kim, Y.D., Hwang, D., Jeong, K.-S.
    • Year: 2018
    • Citations: 15
  • Recurrent Variations in DNA Methylation in Human Pluripotent Stem Cells and Their Differentiated Derivatives
    • Authors: Nazor, K.L., Altun, G., Lynch, C., Loring, J.F., Laurent, L.C.
    • Year: 2012
    • Citations: 316
  • The Effects of the Physical Properties of Culture Substrates on the Growth and Differentiation of Human Embryonic Stem Cells
    • Authors: Lee, S., Kim, J., Park, T.J., Kang, S., Park, H.-S.
    • Year: 2011
    • Citations: 29
  • Comparison of Mesenchymal-like Stem/Progenitor Cells Derived from Supernumerary Teeth with Stem Cells from Human Exfoliated Deciduous Teeth
    • Authors: Lee, S., An, S., Kang, T.H., Kwak, C.K., Park, H.-S.
    • Year: 2011
    • Citations: 29

Pengyi Liu | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Pengyi Liu | Medicine and Dentistry | Best Researcher Award

Doctoral student at Shanghai Ruijin Hospital, China

Dr. Pengyi Liu is a dedicated researcher specializing in the tumor immune microenvironment of pancreatic cancer. Currently pursuing a doctoral degree at Ruijin Hospital, Shanghai Jiaotong University, Liu’s work focuses on understanding the roles of macrophages and T cells in tumor progression. With a Bachelor’s degree in Clinical Medicine, Liu has consistently excelled academically, earning numerous honors, including multiple scholarships and recognition as an “Outstanding Graduate.” Their research has led to significant publications in high-impact journals, exploring novel mechanisms in pancreatic cancer, such as macrophage differentiation and immune response modulation. Proficient in various experimental techniques like cell culture, flow cytometry, and molecular biology, Liu demonstrates a broad skill set essential for cutting-edge cancer research. Their collaborative efforts and innovative approaches continue to advance the field, offering potential new targets for diagnosis and treatment. Liu’s work holds promise for improving clinical outcomes in pancreatic cancer patients.

Professional Profile

Education

Dr. Pengyi Liu’s educational journey reflects a strong foundation in clinical medicine and research. He completed his Bachelor’s degree in Clinical Medicine at Shanghai Jiaotong University from 2016 to 2021, achieving a commendable GPA of 3.63. During this time, Liu was recognized for his academic excellence, earning multiple scholarships and being named a “Merit Student” in 2020. After completing his undergraduate studies, Liu continued his education at Ruijin Hospital, affiliated with Shanghai Jiaotong University School of Medicine, where he is currently pursuing a Doctor of Surgery degree under the prestigious “Zhiyuan Honors Program.” His research is guided by Prof. Baiyong Shen, focusing on the molecular mechanisms of pancreatic cancer. In addition to his rigorous academic training, Liu has taken a wide range of courses, including Anatomy, Physiology, Molecular Biology, Immunology, and Laboratory Animal Science, providing him with a well-rounded knowledge base for his advanced research.

Professional Experience

Dr. Pengyi Liu’s professional experience is centered around groundbreaking research in the field of pancreatic cancer. Currently a doctoral candidate at Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Liu is engaged in advanced research on the tumor immune microenvironment, particularly the roles of macrophages and T cells in tumor progression. Under the mentorship of Prof. Baiyong Shen, Liu has contributed to numerous high-impact publications on pancreatic cancer, including studies on macrophage differentiation, immune modulation, and tumor progression. His research projects are multifaceted, encompassing both molecular and animal model-based approaches to uncover novel mechanisms and potential therapeutic targets. Liu is proficient in various laboratory techniques, including cell culture, flow cytometry, molecular biology assays, and the construction of patient-derived xenograft and organoid models. His work continues to shape the understanding of pancreatic cancer, offering new insights into its diagnosis, treatment, and the development of targeted therapies.

Research Interests

Dr. Pengyi Liu’s research interests are centered around the tumor immune microenvironment, with a particular focus on pancreatic cancer. His work aims to understand the complex interactions between immune cells, such as macrophages and T cells, and tumor progression. Liu is dedicated to uncovering the molecular mechanisms that drive pancreatic cancer, especially how immune cells contribute to the tumor environment and influence cancer growth. His research explores the roles of various molecules, including lncRNAs and signaling pathways, in shaping the immune response and tumor microenvironment. By studying the molecular and cellular processes in pancreatic cancer, Liu aims to identify potential therapeutic targets for better diagnosis and treatment strategies. Additionally, Liu’s work involves the development and use of advanced experimental models, such as patient-derived xenografts and organoids, to simulate the tumor environment and test new treatment approaches. His goal is to bridge the gap between basic research and clinical application in oncology.

Awards and Honors

Dr. Pengyi Liu has received numerous awards and honors throughout his academic career, reflecting his exceptional performance and dedication to research. He was awarded the prestigious scholarships of Shanghai Jiaotong University in 2017, 2018, 2019, and 2020, which recognize his academic excellence. In 2020, he was named a “Merit Student,” further highlighting his outstanding achievements. Dr. Liu’s dedication to his studies was also acknowledged when he was recognized as an “Outstanding Graduate” in 2021, a testament to his strong academic record and research contributions. Additionally, as a graduate student, he was awarded the First-Class Scholarship in 2022 and the Second-Class Scholarship in 2023, underscoring his continued academic excellence and research productivity. These accolades demonstrate not only his commitment to excellence but also the recognition he has earned from his peers and academic community for his hard work and significant contributions to the field of medical research.

Conclusion

Pengyi Liu’s academic achievements, extensive research experience, and significant contributions to understanding the tumor immune microenvironment in pancreatic cancer make them a strong contender for the Best Researcher Award. With a clear focus on advancing scientific knowledge and potential for real-world impact, Liu exemplifies the qualities of a leading researcher. Continued diversification of their research scope and greater emphasis on clinical applications could further amplify their contributions to the field.

Publications Top Noted

  1. Comprehensive analysis of KLF family reveals KLF6 as a promising prognostic and immune biomarker in pancreatic ductal adenocarcinoma
    • Authors: Lin, J., Liu, P., Sun, K., Wang, T., Shen, B.
    • Year: 2024
    • Journal: Cancer Cell International
    • Citations: 0
  2. Pan-cancer analysis implicates novel insights of lactate metabolism into immunotherapy response prediction and survival prognostication
    • Authors: Chen, D., Liu, P., Lu, X., Li, H., Shen, B.
    • Year: 2024
    • Journal: Journal of Experimental and Clinical Cancer Research
    • Citations: 0
  3. ATF3-induced activation of NF-κB pathway results in acquired PARP inhibitor resistance in pancreatic adenocarcinoma
    • Authors: Liu, Y., Cao, Y., Liu, P., Wang, W., Shen, B.
    • Year: 2024
    • Journal: Cellular Oncology
    • Citations: 2
  4. BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1
    • Authors: Cao, Y., Wang, X., Liu, Y., Jiang, L., Shen, B.
    • Year: 2024
    • Journal: Advanced Science
    • Citations: 3
  5. CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization
    • Authors: Liu, Y., Liu, P., Duan, S., Jiang, Y., Shen, B.
    • Year: 2024
    • Journal: Cell Death and Differentiation
    • Citations: 0
  6. SNHG17 alters anaerobic glycolysis by resetting phosphorylation modification of PGK1 to foster pro-tumor macrophage formation in pancreatic ductal adenocarcinoma
    • Authors: Lin, J., Liu, Y., Liu, P., Bao, H., Lin, J.
    • Year: 2023
    • Journal: Journal of Experimental and Clinical Cancer Research
    • Citations: 0
  7. A microprotein N1DARP encoded by LINC00261 promotes Notch1 intracellular domain (N1ICD) degradation via disrupting USP10-N1ICD interaction to inhibit chemoresistance in Notch1-hyperactivated pancreatic cancer
    • Authors: Zhai, S., Lin, J., Ji, Y., Deng, X., Shen, B.
    • Year: 2023
    • Journal: Cell Discovery
    • Citations: 10
  8. Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment
    • Authors: Wang, L., Liu, Y., Dai, Y., Chen, S., Shen, B.
    • Year: 2023
    • Journal: Gut
    • Citations: 100
  9. LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma
    • Authors: Liu, Y., Shi, M., He, X., Sun, B., Shen, B.
    • Year: 2022
    • Journal: Journal of Hematology and Oncology
    • Citations: 76

Tingting Gao | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Tingting Gao | Medicine and Dentistry | Best Researcher Award

Doctor at Shanxi medical university, China

Dr. Tingting Gao is a dedicated and accomplished medical researcher with a strong focus on vascular surgery, immunometabolomics, and multimodal molecular imaging. She is currently pursuing her Doctor of Medicine and Master of Medicine at Shanxi Medical University, where she works under the guidance of Professor Honglin Dong. With a broad range of research interests and expertise in cutting-edge imaging technologies, Dr. Gao has made significant contributions to the understanding of vascular diseases, atherosclerosis, and kidney injury. Her work bridges the gap between experimental biology and clinical applications, demonstrating a commitment to advancing both basic and translational research.

Professional Profile

Education

Dr. Tingting Gao is currently completing her Doctor of Medicine and Master of Medicine at Shanxi Medical University, Taiyuan, China. She has been under the academic mentorship of Dr. Honglin Dong, MD, Ph.D., Assistant Dean of The Second Hospital of Shanxi Medical University. Her education has provided her with a strong foundation in both medical practice and research, allowing her to contribute to the field of vascular surgery while pursuing advanced studies in molecular medicine and disease mechanisms. Her educational journey emphasizes her dedication to both scientific inquiry and clinical expertise.

Professional Experience

Dr. Gao’s professional experience includes significant roles as a Research Assistant in the Department of Vascular Surgery at The Second Hospital of Shanxi Medical University, where she has worked from 2023 to the present. In this role, she conducts research focused on immunometabolomics and multimodal molecular imaging of vascular diseases. She has also worked as a subject participant in various research projects, such as the study of aortic aneurysms and contrast-induced acute kidney injury. Additionally, Dr. Gao has extensive clinical experience in vascular surgery, having worked from 2018 to 2022 in the same hospital, gaining hands-on expertise in patient care and surgical procedures.

Research Interests

Dr. Gao’s research interests span several domains, including vascular surgery, atherosclerosis, liver disease, and imaging technologies. She is particularly interested in the mechanisms underlying vascular diseases, such as atherosclerosis, and how substances like garlic can impact these conditions. Her work integrates network pharmacology, bioinformatics, and experimental verification to explore therapeutic pathways like ferroptosis. Additionally, she focuses on advanced imaging techniques, such as photoacoustic microscopy and magnetic nanoparticle imaging, to better understand disease mechanisms and improve diagnostic tools. Her multidisciplinary approach blends laboratory research with clinical applications, aiming to make a significant impact in both fields.

Awards and Honors

Dr. Gao has received recognition for her research contributions through various awards and honors. She has been a part of multiple funded projects, including those by the Shanxi Provincial Science and Technology Department and the Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi Province. These grants have supported her participation in cutting-edge research exploring vascular diseases, kidney injury, and novel imaging technologies. Dr. Gao’s dedication to her field has also been acknowledged by her peers, reflected in her impressive publication record and active participation in international conferences, where she has presented her findings at major forums like the World Molecular Imaging Society.

Conclusion

The individual appears highly deserving of the Best Researcher Award due to their comprehensive academic background, impressive publication record, technical expertise, and contributions to advanced research in vascular diseases, imaging technologies, and pharmacology. They have demonstrated creativity and leadership in scientific exploration, with innovative work that holds significant potential for clinical applications. However, future opportunities for growth could include assuming more independent leadership roles, increasing international recognition, and further advancing the clinical impact of their research.

Publications Top Noted

  1. Title: Highly sensitive magnetic particle imaging of abdominal aortic aneurysm NETosis with anti-Ly6G iron oxide nanoparticles
    Authors: Wang, H., Zhang, R., Jia, X., Hui, H., Dong, H.
    Year: 2024
    Citations: 0
  2. Title: Exploring the therapeutic potential of garlic in alcoholic liver disease: a network pharmacology and experimental validation study
    Authors: Gao, S., Gao, T., Li, L., Zhou, Y., Dong, H.
    Year: 2024
    Citations: 0
  3. Title: Nobiletin alleviates atherosclerosis by inhibiting lipid uptake via the PPARG/CD36 pathway
    Authors: Wang, H., Tian, Q., Zhang, R., Zheng, G., Dong, H.
    Year: 2024
    Citations: 2
  4. Title: The Protective Role of Intermedin in Contrast-Induced Acute Kidney Injury: Enhancing Peritubular Capillary Endothelial Cell Adhesion and Integrity Through the cAMP/Rac1 Pathway
    Authors: Gao, T., Gu, R., Wang, H., Zheng, G., Dong, H.
    Year: 2024
    Citations: 0
  5. Title: The Down-Shifting Luminescence of Rare-Earth Nanoparticles for Multimodal Imaging and Photothermal Therapy of Breast Cancer
    Authors: Gao, T., Gao, S., Li, Y., Zhang, R., Dong, H.
    Year: 2024
    Citations: 0
  6. Title: Case Report: The application of novel imaging technologies in lower extremity peripheral artery disease: NIR-II imaging, OCTA, and LSFG
    Authors: Ning, Y., Hu, J., Li, H., Zhang, R., Dong, H.
    Year: 2024
    Citations: 0
  7. Title: Garlic ameliorates atherosclerosis by regulating ferroptosis pathway: an integrated strategy of network pharmacology, bioinformatic and experimental verification
    Authors: Gao, T., Gao, S., Wang, H., Zhou, Y., Dong, H.
    Year: 2024
    Citations: 0
  8. Title: Metabolomics and network pharmacology exploration of the effects of bile acids on carotid atherosclerosis and potential underlying mechanisms
    Authors: Cheng, X., Zhang, R., Qi, X., Zheng, G., Dong, H.
    Year: 2024
    Citations: 0
  9. Title: High estrogen induces trans-differentiation of vascular smooth muscle cells to a macrophage-like phenotype resulting in aortic inflammation via inhibiting VHL/HIF1a/KLF4 axis
    Authors: Zhang, R., Wang, H., Cheng, X., Zheng, G., Dong, H.
    Year: 2024
    Citations: 0
  10. Title: Neutrophil Extracellular Traps Aggravate Contrast-Induced Acute Kidney Injury by Damaging Glomeruli and Peritubular Capillaries
    Authors: Wang, H., Gao, T., Zhang, R., Zheng, G., Dong, H.
    Year: 2023
    Citations: 5

Guoping Zheng | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Assoc. Prof. Dr. Guoping Zheng | Medicine and Dentistry | Best Researcher Award

Laboratory head at University of Sydney (WIMR), Australia

Associate Professor Guoping Zheng is a renowned researcher and academic in the field of medicine, specializing in kidney injury, repair, and fibrosis. He is currently an Associate Professor at the University of Sydney, within the Faculty of Medicine and Health, and holds a prestigious NHMRC Principal Research Fellowship at the Westmead Institute for Medical Research. Dr. Zheng has led pioneering research projects in kidney transplantation, fibrosis, and inflammatory diseases, contributing significantly to our understanding of kidney pathophysiology and potential therapeutic interventions. With a research portfolio that spans over two decades, Dr. Zheng has garnered international recognition for his innovative work in renal medicine, including developing engineered macrophages for treating chronic kidney disease. His research impact is further demonstrated by his high citation index, editorial roles in top journals, and his numerous academic and institutional leadership positions.

Professional Profile

Education

Dr. Guoping Zheng has an impressive educational background in medical and molecular sciences. He earned his PhD from the University of Sydney’s Faculty of Medicine, where he conducted research from 1998 to 2002. Before that, he completed a Master of Medicine by research at Shanxi Medical University in China, specializing in biochemistry and molecular biology from 1985 to 1988. Dr. Zheng also holds an MBBS degree from the same institution, completed in 1985. His educational journey laid a strong foundation for his future research and teaching career, enabling him to contribute extensively to the understanding of kidney disease, renal fibrosis, and related inflammatory processes.

Professional Experience

Dr. Zheng has held a distinguished academic career, with extensive roles at the University of Sydney and the Westmead Institute for Medical Research (WIMR). Since 2003, he has been a key figure at the Centre for Transplantation and Renal Research, where he currently serves as an Associate Professor and leads the Kidney Injury Repair and Fibrosis Study Group. His prior roles include Senior Research Officer and Research Officer, with a focus on kidney pathology. Dr. Zheng has also been an NHMRC Peter Doherty Fellow and a lecturer at the University of Sydney. His professional trajectory reflects a deep commitment to advancing medical research and education, particularly in the field of nephrology and renal transplantation. Additionally, Dr. Zheng has held several executive committee positions at WIMR and serves as a mentor and reviewer for multiple research bodies and academic institutions globally.

Research Interests

Dr. Zheng’s research focuses on kidney injury, repair mechanisms, and fibrosis, particularly in the context of chronic kidney disease and renal transplantation. His work aims to uncover novel therapeutic strategies for kidney fibrosis, a key driver of kidney failure. Dr. Zheng has explored several molecular pathways, including the role of macrophages, TGF-β signaling, and matrix metalloproteinases in fibrosis and inflammation. His research also investigates the potential of engineered cells, such as chimeric antigen receptor macrophages, to prevent kidney damage. Another significant area of interest includes the differentiation of pro-fibrotic from anti-inflammatory effects of TGF-β in kidney fibrosis, which may lead to more effective treatments for renal diseases. Dr. Zheng’s interdisciplinary approach bridges biochemistry, molecular biology, and clinical medicine, advancing both basic science and therapeutic innovation in renal health.

Awards and Honors

Dr. Zheng has received numerous awards and honors throughout his distinguished career, recognizing his outstanding contributions to medical research. He has been awarded the prestigious Westmead Millennium Institute Science Prize five times (2006, 2010, 2013, 2017, and 2021), which is granted to the best original research within his institution. Additionally, he was a finalist for the Basic Science Award at both the 55th ANZSN Annual Scientific Meeting (2020) and the 5th Asian Pacific Congress of Nephrology (2016). Dr. Zheng has also received various recognitions for his poster presentations and research symposia, including multiple “Best Poster Presentation Prizes” at the Annual Research Symposium during Hospital Week. These honors reflect his ongoing dedication to advancing scientific understanding in nephrology and transplantation. Moreover, he has been recognized internationally with travel awards and fellowships, including the New Investigator Travel Award for the Pan-Pacific Connective Tissue Societies Symposium in 1999.

Conclusion

Associate Professor Guoping Zheng stands as a highly suitable candidate for the Best Researcher Award. His extensive research experience, influential publications, multiple awards, and leadership in renal medicine demonstrate a strong commitment to advancing medical knowledge and treatment options for kidney disease. Areas of further development, such as advancing his work’s clinical translation and expanding international collaborations, could add even more depth to his already impressive career. Overall, Dr. Zheng’s accomplishments, recognized expertise, and continuous contributions make him a deserving candidate for this prestigious recognition.

Publications Top Noted

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
    • Authors: DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, …
    • Year: 2021
    • Citations: 10,941
  2. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
    • Authors: DJ Klionsky, H Abeliovich, P Agostinis, DK Agrawal, G Aliev, DS Askew, …
    • Year: 2008
    • Citations: 2,962
  3. E‐Cadherin/β‐Catenin Complex and the Epithelial Barrier
    • Authors: X Tian, Z Liu, B Niu, J Zhang, TK Tan, SR Lee, Y Zhao, DCH Harris, …
    • Year: 2011
    • Citations: 610
  4. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease
    • Authors: Y Wang, YP Wang, G Zheng, VWS Lee, L Ouyang, DHH Chang, …
    • Year: 2007
    • Citations: 449
  5. IL-10/TGF-β–modified macrophages induce regulatory T cells and protect against adriamycin nephrosis
    • Authors: Q Cao, Y Wang, D Zheng, Y Sun, Y Wang, VWS Lee, G Zheng, TK Tan, …
    • Year: 2010
    • Citations: 319
  6. Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-β1 in renal tubular epithelial …
    • Authors: G Zheng, JG Lyons, TK Tan, Y Wang, TT Hsu, D Min, L Succar, …
    • Year: 2009
    • Citations: 286
  7. Characterization of murine macrophages from bone marrow, spleen and peritoneum
    • Authors: C Wang, X Yu, Q Cao, Y Wang, G Zheng, TK Tan, H Zhao, Y Zhao, …
    • Year: 2013
    • Citations: 273
  8. Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease
    • Authors: J Lu, QI Cao, D Zheng, Y Sun, C Wang, X Yu, YA Wang, VWS Lee, …
    • Year: 2013
    • Citations: 254
  9. Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells
    • Authors: TK Tan, G Zheng, TT Hsu, Y Wang, VWS Lee, X Tian, Y Wang, Q Cao, …
    • Year: 2010
    • Citations: 185
  10. Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases
    • Authors: H Zhao, Y Dong, X Tian, TK Tan, Z Liu, Y Zhao, Y Zhang, DCH Harris, …
    • Year: 2013
    • Citations: 177
  11. Matrix metalloproteinase-9 of tubular and macrophage origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin cleavage
    • Authors: T Kui Tan, G Zheng, TT Hsu, S Ra Lee, J Zhang, Y Zhao, X Tian, Y Wang, …
    • Year: 2013
    • Citations: 175
  12. CD4+ CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease
    • Authors: D Mahajan, Y Wang, X Qin, Y Wang, G Zheng, YM Wang, SI Alexander, …
    • Year: 2006
    • Citations: 173
  13. Potentiating tissue-resident type 2 innate lymphoid cells by IL-33 to prevent renal ischemia-reperfusion injury
    • Authors: Q Cao, Y Wang, Z Niu, C Wang, R Wang, Z Zhang, T Chen, XM Wang, …
    • Year: 2018
    • Citations: 114
  14. Renal F4/80+ CD11c+ mononuclear phagocytes display phenotypic and functional characteristics of macrophages in health and in adriamycin nephropathy
    • Authors: Q Cao, Y Wang, XM Wang, J Lu, VWS Lee, Q Ye, H Nguyen, G Zheng, …
    • Year: 2015
    • Citations: 112
  15. Transfused macrophages ameliorate pancreatic and renal injury in murine diabetes mellitus
    • Authors: D Zheng, Y Wang, Q Cao, VWS Lee, G Zheng, Y Sun, TK Tan, Y Wang, …
    • Year: 2011
    • Citations: 100

Napoliane Santos | Medicine and Dentistry | Women Researcher Award

Published on by Global Scholar Awards

Mrs. Napoliane Santos | Medicine and Dentistry | Women Researcher Award

Medica at Intituto brasileiro de medicina regenerativa, Brazil

Dr. Napoliane Costa Santos is a skilled radiologist and ultrasonography specialist with extensive experience in patient-focused diagnostic imaging. Driven by a commitment to provide compassionate care, she combines her technical expertise with a mission to ensure that patients feel comfortable and well-supported during their medical exams. Her career spans over a decade, during which she has contributed significantly to multiple healthcare institutions, specializing in general ultrasonography, pain intervention, and regenerative medicine. Her dedication to patient care and her proactive approach in advanced medical imaging make her a standout professional in her field. Additionally, she is deeply involved in medical education, where she shares her expertise with emerging healthcare professionals, furthering the field of ultrasonography and enhancing patient outcomes through her leadership.

Professional Profile

Education

Dr. Santos has a well-rounded educational background, beginning with her medical degree from the Universidade do Estado do Pará in 2012. Following this, she completed a medical residency at Hospital Maternidade Frei Galvão, a program accredited by the Brazilian College of Radiology. Her formal education continued with specialized certifications, including a Diagnostic Imaging specialization in General Ultrasonography, recognized by a national board in 2018. More recently, she pursued postgraduate studies in pain intervention and regenerative medicine at Orthoregen, Brazil, enhancing her expertise in minimally invasive techniques for pain relief. Other certifications include postgraduate work in musculoskeletal imaging, thermography, and clinical pain, showing her continuous pursuit of knowledge and advanced skills in radiology and ultrasonography.

Professional Experience

Dr. Santos’s career is marked by her longstanding roles in numerous reputable healthcare settings. Since 2013, she has been an ultrasonography specialist at Hospital Maternidade Frei Galvão in Guaratinguetá, where she performs general ultrasound exams. Her expertise in pain intervention led her to positions at Clínica Moverti and Hospital Policlin in São Paulo, where she has practiced since 2019 and 2017, respectively. Additionally, she contributes to the BIRM Instituto Brasileiro de Medicina Regenerativa and Orthoregen, focusing on clinical research, pain intervention, and regenerative medicine. At Orthoregen, she also serves as an instructor, training other healthcare providers in advanced ultrasonography techniques, further broadening her impact within the field.

Research Interests

Dr. Santos’s research interests are centered on the applications of diagnostic imaging in managing chronic pain and regenerative medicine. Her focus on ultrasonography-guided, minimally invasive pain treatments addresses a significant area in modern healthcare, particularly for patients with musculoskeletal disorders. She is especially interested in exploring how advancements in ultrasonography can enhance patient outcomes in musculoskeletal and rheumatologic conditions. Her work at Orthoregen and BIRM reflects her dedication to integrating clinical research with practical applications, aiming to advance the fields of pain intervention and regenerative medicine. Through ongoing studies and clinical practices, she continues to contribute to research that seeks innovative, non-invasive solutions for chronic pain.

Awards and Honors

While Dr. Santos has yet to receive major publicized awards, her growing expertise and roles in esteemed institutions highlight her accomplishments. Her board certification as a Diagnostic Imaging Specialist by the Brazilian College of Radiology reflects a high level of professional recognition. Her responsibilities as an instructor in ultrasonography and pain intervention signify trust in her abilities to lead and mentor, which is a significant professional honor. As her clinical and research contributions gain visibility, Dr. Santos stands poised for recognition in healthcare and research awards, particularly those honoring advancements in diagnostic radiology and compassionate patient care. Her dedication to her field is evident, positioning her as a respected professional and potential candidate for future honors.

Conclusion

Napoliane Costa Santos possesses a strong foundation for the Women Researcher Award due to her depth of clinical expertise, specialized training in ultrasonography and pain management, and commitment to patient care. She demonstrates both technical skill and compassionate care, essential qualities in healthcare research and practice. However, to strengthen her candidacy, a greater focus on documented research contributions, leadership in scientific projects, and published innovations would be advantageous. Overall, she is a promising candidate with potential to make a meaningful impact through further academic and research pursuits in her field.

Publications Top Noted

  1. SDIMMMER: A Proposed Clinical Approach to Optimize Cellular Physiology in Regenerative Medicine
    • Authors: Lana, J.V., Lana, J.F., Melo, G., Pires, L., Tambeli, C.H.
    • Year: 2024
    • Citation Count: 0
  2. Regenerative Inflammation: The Mechanism Explained from the Perspective of Buffy-Coat Protagonism and Macrophage Polarization
    • Authors: Martins, R.A., Costa, F.R., Pires, L., Kruel, A., Lana, J.F.
    • Year: 2024
    • Citation Count: 0
  3. Nebulized Glutathione as a Key Antioxidant for the Treatment of Oxidative Stress in Neurodegenerative Conditions
    • Authors: Lana, J.V., Rios, A., Takeyama, R., Purita, J., Lana, J.F.
    • Year: 2024
    • Citation Count: 3
  4. The Biological Role of Platelet Derivatives in Regenerative Aesthetics
    • Authors: Santos, L.C., Lana, G.L., Santos, G.S., Tambeli, C.H., Lana, J.F.
    • Year: 2024
    • Citation Count: 4
  5. Sacral Bioneuromodulation: The Role of Bone Marrow Aspirate in Spinal Cord Injuries
    • Authors: Lana, J.F., Navani, A., Jeyaraman, M., de Moraes Ferreira Jorge, D., Purita, J.
    • Year: 2024
    • Citation Count: 0
  6. The Role of Orthobiologics in Chronic Wound Healing
    • Authors: Domingues, R.B., von Rautenfeld, M., Kavalco, C.M., Everts, P., Lana, J.F.
    • Year: 2024
    • Citation Count: 4

Olgica Mihaljevic | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Prof. Olgica Mihaljevic | Medicine and Dentistry | Best Researcher Award

Prof at University of Kragujevac, Serbia, Faculty of Medical sciences, Department of Pathophysiology, Serbia

Prof. Olgica Mihaljevic, a distinguished medical researcher and educator, specializes in pathophysiology with a focus on internal medicine, carcinoma, thyroid diseases, and public health. She earned her PhD with a thesis on apoptosis and oxidative stress in thyroid carcinoma patients, showcasing her expertise in cellular mechanisms related to cancer. With over 15 years of experience, Mihaljevic has held various academic positions, including her current role as head of the pathophysiology department, and teaches at the Military Medical Academy in Belgrade. Her research contributions are extensive, addressing critical health issues like COVID-19, cancer screening, and healthcare disparities. A committed member of professional bodies, she is vice president of the Pathophysiology Section of the Serbian Medical Association. Mihaljevic’s work in high-impact areas and dedication to medical education and public health make her a highly respected figure in Serbia’s medical community and a strong candidate for research accolades.

Professional Profile

Education

Prof. Olgica Mihaljevic completed her medical education at the Faculty of Medical Sciences, University of Kragujevac, where she earned her medical degree in 2007 with an impressive average grade of 9.83. Following her undergraduate studies, she pursued postgraduate education in Clinical and Experimental Internal Medicine at the same institution, achieving an average grade of 9.0. In 2014, she completed her PhD with a thesis focused on the changes in apoptosis of lymphocytes, oxidative stress parameters, and cytokine profiles in patients with differentiated thyroid carcinoma. This research highlighted her expertise in understanding the molecular and biochemical mechanisms behind thyroid diseases and cancer. Her academic journey has been marked by excellence, reflected in both her grades and the depth of her research in critical areas of internal medicine, oncology, and public health. Prof. Mihaljevic’s strong educational background laid the foundation for her successful academic and professional career.

Professional Experience

Prof. Olgica Mihaljevic has over 15 years of professional experience in both research and education. She began her academic career in 2008 as a teaching assistant in the Department of Pathophysiology at the Faculty of Medical Sciences, University of Kragujevac, where she progressed to assistant and later assistant professor by 2016. During this time, she contributed to the education of medical students and the development of curriculum in pathophysiology. In 2017, she became the head of the Department of Pathophysiology in basic dental studies and later took on a role as a lecturer at the Military Medical Academy in Belgrade. In 2023, she was appointed head of the Department of Pathophysiology for basic medical studies in English at the University of Kragujevac. In addition to her academic roles, Mihaljevic is actively involved in medical research, publishing extensively on topics such as cancer, oxidative stress, and public health.

Research Interests

Prof. Olgica Mihaljevic’s research interests span several critical areas of medicine, with a strong focus on internal medicine, dermatology, and oncology. Her work primarily investigates the pathophysiology of thyroid gland diseases, particularly thyroid carcinoma, where she explores cellular mechanisms like apoptosis, oxidative stress, and cytokine profiles. Additionally, she studies the molecular aspects of autoimmune diseases, nephrology, and radiotherapy. Mihaljevic has a keen interest in the role of genome damage in disease progression, especially in cancer. She is also committed to understanding the broader impacts of public health, focusing on the sociodemographic factors influencing cancer screenings and healthcare access. Her research aims to bridge the gap between clinical practices and molecular biology, improving patient care and disease management. Prof. Mihaljevic’s contributions are especially relevant in addressing major health challenges like cancer, autoimmune disorders, and the effects of oxidative stress, making her research crucial to both medical science and public health.

Awards and Honors

Prof. Olgica Mihaljevic has earned numerous accolades throughout her career, reflecting her dedication to research and education in the medical field. As a highly respected academic, she has been recognized for her contributions to pathophysiology and public health. Prof. Mihaljevic holds several key leadership roles in professional medical organizations, including being a vice president of the Pathophysiology Section of the Serbian Medical Association. She is also an active member of the Serbian Medical Society and the Medical Chamber of Serbia. Her commitment to advancing medical science is evident in her editorial role on the Medical Journal of the Serbian Medical Society, where she contributes to the dissemination of critical research. Through her research, especially in cancer, oxidative stress, and healthcare disparities, Prof. Mihaljevic has garnered recognition from both national and international medical communities. Her academic and research achievements solidify her reputation as a leader in her field.

Conclusion

Olgica Mihaljevic is a highly qualified candidate for the Best Researcher Award, given her extensive expertise, research contributions, and leadership in medical sciences. Her focus on significant health issues like carcinoma, oxidative stress, and public health aligns well with the award’s purpose of recognizing impactful medical research. With strategic enhancements in international collaboration and funding acquisition, she could further amplify her contributions to the field. Overall, Mihaljevic demonstrates the attributes and achievements that make her a worthy candidate for this awar

Publications Top Noted

  • Title: Laboratory Puzzle of Oxidative Stress, Parameters of Hemostasis and Inflammation in Hospitalized Patients with COVID-19
    Authors: Djordjevic, J., Ignjatovic, V., Vukomanovic, V., Stanojevic Pirkovic, M., Mihaljevic, O.
    Journal: Biomedicines
    Year: 2024
    Volume: 12(3), 636
    Citations: 1
  • Title: Socioeconomic and Health Characteristics as Predictors of Social Support in Elderly People with Visual Impairment: Evidence from Serbia
    Authors: Djurovic, N., Radovanovic, S., Mihaljevic, O., Vasiljevic, D., Selakovic, V.
    Journal: Iranian Journal of Public Health
    Year: 2024
    Volume: 53(10), 2251-2259
    Citations: 0
  • Title: Sociodemographic Factors Associated with Breast Cancer Screening Among Women in Serbia, National Health Survey
    Authors: Djordjević, S., Dimitrijev, I., Boričić, K., Sorak, M., Jovanović, V.
    Journal: Iranian Journal of Public Health
    Year: 2024
    Volume: 53(2), 387–396
    Citations: 0
  • Title: Transforming Growth Factor Beta 1 (TGF-β1) in COVID-19 Patients: Relation to Platelets and Association with the Disease Outcome
    Authors: Zivancevic-Simonovic, S., Minic, R., Cupurdija, V., Jakovljevic, V., Mihaljevic, O.
    Journal: Molecular and Cellular Biochemistry
    Year: 2023
    Volume: 478(11), 2461–2471
    Citations: 6
  • Title: Oxidative Stress and DNA Damage in Critically Ill Patients with Sepsis
    Authors: Mihaljevic, O., Zivancevic-Simonovic, S., Jovanovic, D., Jakovljevic, V., Milosevic-Djordjevic, O.
    Journal: Mutation Research – Genetic Toxicology and Environmental Mutagenesis
    Year: 2023
    Volume: 889, 503655
    Citations: 2
  • Title: Effect of the COVID-19 Pandemic on Surgery for Indeterminate Thyroid Nodules (THYCOVID): A Retrospective, International, Multicenter, Cross-sectional Study
    Authors: Medas, F., Dobrinja, C., Al-Suhaimi, E.A., Zahid, M.T., Zielke, A., Mihaljevic, O.
    Journal: The Lancet Diabetes and Endocrinology
    Year: 2023
    Volume: 11(6), 402–413
    Citations: 11
  • Title: Pathophysiological and Laboratory Aspects of Hemostatic Disorders in Patients with COVID-19
    Authors: Đorđević, J., Mihaljević, O., Pirković, M.S., Radović, M., Babović, B.
    Journal: Acta Facultatis Medicae Naissensis
    Year: 2023
    Volume: 40(4), 402–414
    Citations: 0
  • Title: Demographic and Socioeconomic Factors Associated with Cervical Cancer Screening Among Women in Serbia
    Authors: Djordjevic, S., Boricic, K., Radovanovic, S., Mihaljevic, O., Jovanovic, V.
    Journal: Frontiers in Public Health
    Year: 2023
    Volume: 11, 1275354
    Citations: 1